Plasma Exchange in Non-Haemophiliac Patients With Inhibitors to Factor VIIIC.

BMJ
doi 10.1136/bmj.283.6294.760
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Plasma Levels of Coagulation Inhibitors, Fibrinolytic Markers and Platelet-Derived Growth Factor-Ab in Patients With Failed Hip Prosthesis

Acta Orthopaedica Scandinavica
2003English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients With Advanced Non-Small Cell Lung Cancer

Current Gerontology and Geriatrics Research
GerontologyGeriatrics
2010English

Factor VIII Levels During the Course of Acute Hepatitis in a Haemophiliac.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1975English

Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII

BMJ
1981English

A Patient Having Acquired Factor v Inhibitor Unable to Be Managed by Plasma Exchange

Journal of the Japanese Society of Intensive Care Medicine
2017English

Efficacy of Therapeutic Plasma Exchange in Patients With Severe Refractory Anti-Nmda Receptor Encephalitis

Neurotherapeutics
NeurologyPharmacology
2019English

Clinical Characteristics and Response to Tyrosine Kinase Inhibitors of Patients With Non-Small Cell Lung Cancer Harboring Uncommon Epidermal Growth Factor Receptor Mutations

Chinese Journal of Cancer Research
Cancer ResearchOncology
2017English

Serum Hepatitis in a Haemophiliac.

BMJ
1969English

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Journal of Managed Care Pharmacy
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy